Iris Valtingojer

Iris Valtingojer

Company: Sanofi R&D

Job title: Group Leader, Oncology Research


Hippo-YAP1 Deregulation in Cancer: Opportunity & Challenges for Drug Discovery 3:30 pm

• Hippo-YAP1 deregulation in cancer • Recent advancements in drug discovery • Challenges and unknownsRead more

day: Day One

Leveraging the Hippo Pathway for Therapeutic Intervention – Optimizing Translation, Animal Models & Safety 12:00 pm

As we continue to see more success with drugs targeting the Hippo pathway, it is critical that we consider how to optimize translation and safety to the patient. This panel discussion will consider all important elements to nurture the success of Hippo targeted therapies, including debates on topics surrounding advanced animal models, pharmacology and toxicology,…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.